Avastin Overview

Avastin is the brand name for bevacizumab, a drug that targets a type of protein (VEGF) found in many tumors. By doing so, it helps prevent tumors from spreading to other locations in the body, or metastasizing.

Avastin can be used to treat colon and kidney cancer, and is usually given with traditional chemotherapy drugs.

For more detailed information about Avastin, please visit the Avastin information page.

• Kidney Failure: A Potential Side Effect of Avastin?
  
• Avastin Slows Growth of Colon Cancer
  
• FOLFOX4 Plus Avastin: Worth a Try?
  
• FOLFOX4 Drug Combo Proven Effective
  
• Adding Avastin May Add Years to Your Life

• Another Avastin Warning
  
• Avastin Approved in EU and Switzerland
  
• Avastin Warning
  
• FDA Approval of Avastin as a Colorectal Cancer Treatment

• Combined Analysis of Efficacy: The Addition of Bevacizumab to Fluorouracil/Leucovorin Improves Survival for Patients With Metastatic Colorectal Cancer (abstract)
  
  
• Phase II Study of FOLFOX, Bevacizumab and Erlotinib as First-Line Therapy for Patients with Metastastic Colorectal Cancer (abstract)

• Arterial Thromboembolic Events in Patients with Metastatic Carcinoma Treated with Chemotherapy and Bevacizumab (abstract)
  
  
• Gastrointestinal Perforation Due to Bevacizumab in Colorectal Cancer (abstract)
  
  
• Interstitial Nephritis Secondary to Bevacizumab Treatment in Metastatic Leiomyosarcoma (abstract)